SEQUENCEFOUR

Welcome to the Brand page for “SEQUENCEFOUR”, which is offered here for Apparatus for chemical synthesis; mobile laboratory; mobile device for the synthesis of macromolecules; mobile production station of biological macromolecules;machines; machines for use in chemical or biopharmaceutical industry; bioreactors; apparatus for chemical or biological analysis and/or synthesis; filling machines, in particular for use for filling biopharmaceutical compositions into containers; industry roboters;chemical preparations for medical use, in particular biological macromolecules; pharmaceutical and veterinary preparations; pharmaceuticals and medicines based on biological macromolecules for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for treatment or prevention of infectious diseases, allergies, autoimmune disorders and tumour diseases, for treatment of metabolic disorders and for treatment of inherited genetic diseases or for protein or enzyme replacement therapy; gene therapeutic preparations; health care preparations for medical use; dietetic substances adapted for medical use, in particular substances for food supplements; vaccines;sequence four;chemicals and biomolecules, in particular biological macromolecules, for industrial or scientific purposes; reagents for research purposes;medical and veterinary services, in particular for therapeutic and preventive treatment of tumour diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders; vaccination;scientific and technological services and research, in particular for identification, testing and characterisation of biological molecules; pre-clinical and clinical testing of macromolecules; custom synthesis of chemical compounds, in particular biological macromolecules;.

Its status is currently believed to be active. Its class is unavailable. “SEQUENCEFOUR” is believed to be currently owned by “CUREVAC RNA PRINTER GMBH”.